FDA Inspection 1194053 — University Of Illinois At Chicago Andrology Laboratory
The FDA completed an inspection of University Of Illinois At Chicago Andrology Laboratory on Dec 12, 2022 in Chicago, IL. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Dec 12, 2022
- Fiscal Year
- 2023
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Chicago, IL (United States)